Paul Selzer1, Hans-Jörg Roth, Peter Ertl
1Information and Knowledge Management at Novartis, IK@N, InSilico Sciences, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland. paul.selzer@novartis.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Molecular complexity, measured by structural descriptors, correlates with biological activity. Highly active compounds are generally more complex, but balancing complexity is crucial to avoid pharmacokinetic issues in drug discovery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: